(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HEME QUEEN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

HEME QUEEN

ST13

US500000097546601

Class

41

Filing

97546601

Registration

7580838

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

24

Latest update

11/26/2024

Trademark type

Word

Nice classes

41

Filing date

08/12/2022

Registration date

11/26/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/26/2024

Last transaction

11/26/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/04/2022

First use in commerce

07/21/2024

Drawing code

4

Owner type

16

Owner location

Boston, MA, US

Examiner

BROWN, BARBARA TROFFKIN

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Mededdo LLC

Representatives

Matthew Saunders SAUNDERS & SILVERSTEIN LLP

Technical classification

Nice Classes

Class 41

Vienna Codes

No Vienna codes available.

Goods and services

Class 41

Educational servicesproviding on-line lectures and classes in the field of hematologyhematopathologyclinical pathology and laboratory medicinegeneticspharmacologycellular structure and functioncoagulation and hemostasishemorrhagicthromboticthrombohemorrhagic disorders; Providing online non-downloadable visual and audio recordings featuring lectures and classes in the fields of hematologyhematopathologyclinical pathology and laboratory medicinegeneticspharmacologycellular structure and functioncoagulation and hemostasishemorrhagicthromboticthrombohemorrhagic disorders; Educational and entertainment servicesa continuing program about hematologyhematopathologyclinical pathology and laboratory medicinegeneticspharmacologycellular structure and functioncoagulation and hemostasishemorrhagicthromboticthrombohemorrhagic disorders accessible by means of onlinenon-downloadable videos

Publications

History of USPTO decisions and trademark events.

24 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/26/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

11/26/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/01/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/01/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/11/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/11/2024

IUAF

USE AMENDMENT FILED

08/07/2024

EISU

TEAS STATEMENT OF USE RECEIVED

08/07/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/13/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/19/2023

PUBO

PUBLISHED FOR OPPOSITION

12/19/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/29/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/14/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/13/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/13/2023

ALIE

ASSIGNED TO LIE

11/13/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/08/2023

GEAN

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

06/07/2023

GEAP

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

06/07/2023

EPEN

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY

06/07/2023

CPEA

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

06/07/2023

DOCK

ASSIGNED TO EXAMINER

05/31/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/19/2022

NWAP

NEW APPLICATION ENTERED

08/16/2022

Continuous trademark protection

Get notified about every new filing that threatens HEME QUEEN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.